Auto-generated from public data. Not the firm's stated position.
Convergence Partners AG appears to focus on early-stage healthtech and edtech investments, with a particular emphasis on medical devices and diagnostic AI applications based on disclosed portfolio companies. Recent investments suggest concentration in clinical validation-stage technologies across neurovascular, cognitive health, and imaging sectors, with typical check sizes between €1.5M and €3.0M.
Generated 11 Oct 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].
Focus and check size from the firm's website. Website reachable as of Sept 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.